Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NFYA contributors: mct - updated : 12-12-2016
HGNC name nuclear transcription factor Y, alpha
HGNC id 7804
DNA
TYPE functioning gene
STRUCTURE 29.44 kb     10 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked   status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
10 - 6236 36.9 347 - 2012 22285817
including exon b
9 splicing 6149 33.8 318 - 2012 22285817
lacking alternate exon b
EXPRESSION
Type widely
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Hearing/Equilibriumear   highly
Reproductivemale systemtestis  highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Connectiveadipose  highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a N terminal A domain
  • a highly conserved central B domain involved in DNA binding
  • a C terminal C domain rich in glutamine and acidic residues involved in protein-protein interactions with various genes
  • mono polymer heteromer , trimer
    HOMOLOGY
    interspecies homolog to yeast Hap3 subunit
    Homologene
    FAMILY cbf-a subfamily
    CATEGORY transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • mediating the transcriptional regulation by recognizing the CCAAT motif in promoter
  • mediating the transcriptional regulation of MDR1 by histone acetyltransferase and deaminase
  • mediating the interaction of BRCA1 to GADD45 through its binding to CAAT motif of BRCA1
  • mediating ABCB1 regulation by PCAF
  • potent cellular regulator of hematopoietic stem cell (HSC) self-renewal
  • pivotal upstream participant in a regulatory network necessary for the preservation of cycling hematopoietic stem cell
  • role in the regulation of human proteasome genes
  • CELLULAR PROCESS nucleotide, transcription, regulation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • forming a trimeric complex with NFYB and NFYC
  • CDKN1A/NFYA/PLK1 axis critical for maintaining the checkpoint function of TP53 to prevent mitotic death in the DNA damage-induced response
  • INTERACTION
    DNA binding the CCAAT and the inverted CCAT box,Y box (ATGG) motifs in HLA genes and a variety of promoters
    RNA
    small molecule
    protein
  • binding to NFYB, NFYC
  • functions as a key regulator of SOX3 gene expression
  • interacting with mutant HTT
  • interacting with SARS2 (NFYA, NFYB, NFYC influences directionality of transcription from the bidirectional MRPS12/SARS2 promoter)
  • NFYA, NFYB, NFYC, cooperates with FOXO3 to recruit EP300 to the BCL2L11 promoter to form a stable multi-protein/DNA complex that activates BCL2L11 transcription after survival factor withdrawal
  • CDK2/CCNA2 can phosphorylate and activate the transcription factor NFYA
  • TBP interacts with NFY subunit A (NFYA), which could be a target of mutant TBP in SCA17
  • NFYA, NFYB, NFYC can act as a transcriptional activator of ABCB4
  • ZHX1 interact with the activation domain of the nuclear factor Y subunit A (NFYA) and to have a transcriptional repression activity
  • NFYA, NFYB, NFYC and YY1 are important for the basal transcription of PCYT2 and NFY is involved in the inhibitory effects of 25-HC on PCYT2 transcription
  • cell & other
    REGULATION
    activated by ATF6
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    led to a delay in S-phase progression, DNA damage and apoptosis
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    may be a potential target for cancer therapy
    ANIMAL & CELL MODELS